This Site is published by Laboratoire HRA Pharma, a “Société par Actions Simplifiée” (a private limited company) with a capital of 84 778 228 €, with registered headquarters at 200, avenue de Paris, 92320 Châtillon, France, registered on the Trade and Companies Register under number 420 792 582 R.C.S. Nanterre.

To contact Laboratoire HRA Pharma, click on the following link: https://hra-pharma.com/contact or call +33(0)1 40 33 11 30.

The Site publication director is HERA SAS represented by Svend Andersen, CEO. Laboratoire HRA Pharma is a ‘Laboratoire pharmaceutique” according to the French Public Health Code, licensed by the ANSM (French health Authority).

The Site content is hosted on servers belonging to CLOUD TEMPLE, SAS, with a capital of 1,035,824.€, registered office at Immeuble « Le Clémenceau II » 215 Avenue Georges Clémenceau 92024 Nanterre Cedex, France, registered on the Trade and Companies Register under number 402 336 085.

This site is controlled and operated by Laboratoire HRA Pharma (hereafter “HRA Pharma”), whose headquarters are located at 200, avenue de Paris, 92320 CHATILLON, France (phone: + 33 (0) 1 40 33 11 30). Access to and use of this site are subject to these Terms and Conditions and all applicable laws and regulations. By accessing and using this site, you accept, without limitation or qualification, these Terms and Conditions.

HRA Pharma reserves the right to change these Terms and Conditions from time to time without notice, as it deems necessary; you are therefore advised to check them regularly.

Access to this site is not restricted to health care providers. This site is intended for a global audience.

This site is not intended to be used as a source of medical advice or opinion, or to promote drugs and medical devices. Under no circumstances should anything provided on this site be used to establish a medical diagnosis, which can only be achieved by consulting a qualified doctor.

This site was created to provide all audiences worldwide with general information about HRA Pharma and its products and services. It has been developed in accordance with the principles of European regulations.

You agree that access to and use of this site and the content thereof is at your own risk. HRA Pharma and any party involved in creating, producing or delivering this site hereby expressly exclude:

All conditions, warranties and other terms that might otherwise be implied by statute, common law or the law of equity.
Any liability for any direct, indirect or consequential loss or damage incurred by any user arising out of access to, use of or inability to use this site, or any errors or omissions in the content thereof.
HRA Pharma accepts no liability for any loss or damage caused by a denial of distribution service, attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the audio, video, data or text on the site or any other aspect of the site.

All the products may not be available in all countries, or could be approved with different indications or restrictions. Trademarks could vary from a country to another. The products referred to on this site may be subject to different regulatory requirements, depending on the country of use. Pictures of products are examples of available packagings, and can be updated at any time.

HRA Pharma respects the privacy of its site users, and users should refer to the Privacy Policy for information related to the collection and use of your personal information.

You may not use in any way any of the trademarks and logos used within this site without HRA Pharma’s authorization.

HRA Pharma is the owner or licensee of all copyright in the site. All such rights are reserved.

You may download and retain on your disk or in hard-copy form a single copy of material published on this site only for your personal, non-commercial use, provided that you do not remove any copyright or other proprietary notices. You may not otherwise copy, distribute, display, download, modify, repost, transmit or use all or part of any material without HRA Pharma’s prior written permission. You may not mirror on another web server all or part of any material published by HRA Pharma on this site, and you may not copy any of the graphics contained in any material published on this site.

Nothing contained herein shall be construed as conferring by implication, estoppels or otherwise, any license or right under any patent or trademark of HRA Pharma, or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right to any copyright work of which HRA Pharma is the owner or licensee.

This site may be used as a portal to other sites. However, links or references to other sites maintained by third parties over whom HRA Pharma has no control are provided merely as a convenience. Similarly, this site may be accessed from third party links over which HRA Pharma has no control. HRA Pharma makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information. Inclusion of any third party’s link does not imply an endorsement or recommendation by HRA Pharma.

HRA Pharma reserves the right to alter or delete material from this site at any time without notice.

French laws govern these Terms and Conditions and their interpretation, and the French courts shall have exclusive jurisdiction to settle any dispute arising out of or in connection with these Terms and Conditions.

If any provision of these Terms and Conditions is held to be unlawful, void or unenforceable, then such provision shall be severable without affecting the validity, lawfulness or enforceability of all remaining provisions.

Except as expressly provided, these Terms and Conditions constitute the entire agreement between you and HRA Pharma with respect to the use of this site and content. Last Update March 13th, 2019